Evidence map›Paper›PMID 22665950›Full record

ArticleMediators of inflammation2012

Disruption of the ECM33 gene in Candida albicans prevents biofilm formation, engineered human oral mucosa tissue damage and gingival cell necrosis/apoptosis.

Mahmoud Rouabhia, Abdelhabib Semlali, Jyotsna Chandra, Pranab Mukherjee, Witold Chmielewski, Mahmoud A Ghannoum

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Critical reviews in microbiology · 2021
    Review
  5. Effect ofAntibiotics (Basel, Switzerland) · 2021
    Article
  6. Three-DimensionalTissue engineering. Part B, Reviews · 2020
    Review
  7. Article
  8. mBio · 2018
    Article
  9. Article
  10. Article
  11. Candida albicans Biofilms and Human Disease.Annual review of microbiology · 2015
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Mahmoud RouabhiaGroupe de Recherche en Écologie Buccale, Faculté de Médecine Dentaire, Université Laval Pavillon de Médecine Dentaire, 2420 Rue de la Terrasse, QC G1V 0A6, Canada.
Abdelhabib Semlali
Jyotsna Chandra
Pranab Mukherjee
Witold Chmielewski
Mahmoud A Ghannoum
Case Western Reserve University · USUniversité Laval · CAUniversity Hospitals Case Medical Center · US

Funding

Identification of early phase C. albicans biofilm proteinsR01DE017486 · NIDCR · CASE WESTERN RESERVE UNIVERSITY · PI GHANNOUM, MAHMOUD A · 2007 to 2011
$1.8M
Role of extracellular matrix proteins in Candida biofilm formationR21AI074077 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI MUKHERJEE, PRANAB KUMAR · 2009 to 2010
$432k
NIAID NIH HHS R21 AI074077NIAID NIH HHS R21-AI74077-01NIDCR NIH HHS R01 DE017486NIDCR NIH HHS R01-DE017486-01A1
6 · The paper itself

Abstract

In this study we demonstrated that ΔCaecm33 double mutant showed reduced biofilm formation and causes less damage to gingival mucosa tissues. This was confirmed by the reduced level of necrotic cells and Bax/Bcl2 gene expression as apoptotic markers. In contrast, parental and Caecm33 mutant strains decreased basement membrane protein production (laminin 5 and type IV collagen). We thus propose that ECM33 gene/protein represents a novel target for the prevention and treatment of infections caused by Candida.

Indexed as

ApoptosisBiofilmsCandida albicansCandidiasisCells, CulturedFungal ProteinsGingivaHumansIn Vitro TechniquesMouth MucosaNecrosisFungal Proteins

Identifiers

PMID22665950
PMCPMC3361342
OpenAlexW1985264699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.